TESLIO-D-MET 500 ER Tablet is a triple-combination oral antidiabetic medication formulated with Dapagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride 500 mg (Extended Release). It is indicated for the management of Type 2 Diabetes Mellitus in adults when diet, exercise, and single or dual therapy do not provide adequate glycemic control. The combination works through complementary mechanisms to help improve blood glucose control, reduce HbA1c, and support long-term diabetes management.

Key Benefits

• Triple-action therapy for comprehensive blood glucose control.
• Helps lower HbA1c, fasting blood glucose (FBG), and postprandial blood glucose (PPBG).
• Improves insulin sensitivity and reduces hepatic glucose production.
• Promotes urinary glucose excretion through SGLT2 inhibition.
• Enhances glucose-dependent insulin secretion while reducing glucagon release.
• Extended-release Metformin provides sustained glucose control and improved gastrointestinal tolerability.
• Convenient fixed-dose combination to improve treatment adherence.
  

  Usage

  • Take TESLIO-D-MET 500 ER Tablet exactly as prescribed by your physician.
  • Swallow the tablet whole with water; do not crush, chew, or break the extended-release tablet.
  • Preferably take with food to reduce gastrointestinal discomfort.
  • Follow a healthy diet, regular exercise, and routine blood glucose monitoring for optimal diabetes management.
  • Do not alter the dose or discontinue the medication without consulting your healthcare provider.
    

    Storage

    • Store below 30°C in a cool, dry place.
    • Protect from moisture and direct sunlight.
    • Keep the tablets in their original packaging until use.
    • Keep out of reach of children.